Interdisciplinary management of belantamab mafodotin-associated ocular toxicity in clinical practice.

چکیده

Belantamab mafodotin (BLENREP), an antibody-drug conjugate for relapsed/refractory multiple myeloma (RRMM), is associated with corneal toxicity driven by limbal stem cell dysfunction and corneal epithelial damage. We examined how keratopathy severity relates to hematologic management decisions in…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• قرنیه